Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

The global atopic dermatitis drugs market should grow with a CAGR of 4.77% over the forecast period. The base year considered for the study is 2017 and the forecast period is 2019-2027

ReportBuyer
Posted on: 19 Oct 18
The global atopic dermatitis drugs market should grow with a CAGR of 4.77% over the forecast period. The base year considered for the study is 2017 and the forecast period is 2019-2027

PR Newswire

LONDON, Oct. 18, 2018

LONDON, Oct. 18, 2018 /PRNewswire/ -- KEY FINDINGS
According to market expectations, the global atopic dermatitis drugs market should grow with a CAGR of 4.77% over the forecast period. The base year considered for the study is 2017 and the forecast period is 2019-2027.

Download the full report: https://www.reportbuyer.com/product/5377447

The global atopic dermatitis drugs market is primarily driven by factors such as the increasing prevalence of food allergies causing atopic dermatitis, the rising focus on systematic therapies and the ever increasing use of pharmacological products in developing countries

MARKET INSIGHTS
The important driver increasing growth in the global atopic dermatitis drugs market is the high prevalence of food allergies exacerbating atopic dermatitis.It is estimated that food allergy and severe atopic dermatitis coexist in about one-third of all children with atopic dermatitis.

The atopic dermatitis drugs market is broadly classified into two segments on the basis of drug classes and the route of administration.

REGIONAL INSIGHTS
This report broadly segregates the atopic dermatitis drug market into four geographies namely-Europe, Asia-Pacific, North America and Rest of the World.The atopic dermatitis drugs market in North America is expected to hold the largest share by 2027.

This sudden yet steady growth in the North American regional market is attributed to the high prevalence of allergic conditions in the existing population. The United States holds the largest revenue share in global atopic dermatitis drugs market country-wise.

COMPETITIVE INSIGHTS
Leading players in the global atopic dermatitis drug market are Allergan Plc, Aqua Pharmaceuticals (An Almirall Company), Astellas Pharma Inc., Bayer Ag, Biofrontera Ag,Bristol-Myers Squibb,Stiefel Laboratories Inc, Encore Dermatology, Galderma Sa, Leo Pharma, Meda Pharmaceuticals (Mylan N.V.),Novartis Ag, Pfizer, Regeneron Pharmaceuticals, Sanofi Sa, Valent Pharmaceutical Inc. and several others.

Download the full report: https://www.reportbuyer.com/product/5377447

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/the-global-atopic-dermatitis-drugs-market-should-grow-with-a-cagr-of-4-77-over-the-forecast-period-the-base-year-considered-for-the-study-is-2017-and-the-forecast-period-is-2019-2027--300733807.html

SOURCE ReportBuyer

PR Newswire
www.prnewswire.com

Last updated on: 19/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.